Chih-Jian Lih

Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

Wyndham H. Wilson, Ryan M. Young, Roland Schmitz et al. · Nature Medicine · 2015 · 1.1K citations · Full text

Life Sciences, Oncology, Pharmacology +13

Glioma cells on the run – the migratory transcriptome of 10 human glioma cell lines

Tim Demuth, Jessica L. Rennert, Dominique B. Hoelzinger et al. · BMC Genomics · 2008 · 63 citations · Full text

Medicine, Cell Biology, Oncology +17

Application of Molecular Profiling in Clinical Trials for Advanced Metastatic Cancers

Shivaani Kummar, Paul M. Williams, Chih-Jian Lih et al. · JNCI Journal of the National Cancer Institute · 2015 · 60 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Pharmacodynamic biomarker-driven trial of MK-2206, an AKT inhibitor, with AZD6244 (selumetinib), a MEK inhibitor, in patients with advanced colorectal carcinoma (CRC).

Giovanna Speranza, Robert J. Kinders, Sonny Khin et al. · Journal of Clinical Oncology · 2012 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +15